ECO ANIMAL HEALTH GROUP PLC

Regulatory Filings • Aug 12, 2024

National Storage Mechanism | Additional information

RNS Number : 1230A

Eco Animal Health Group PLC

12 August 2024

ECO Animal Health Group PLC

BLOCK LISTING RETURN

Date: 12 August 2024

Name of applicant:		ECO Animal Health Group plc
Name of scheme:		Executive Share Option Scheme and Unapproved Share Option Scheme
Number and class of securities originally listed and the date of admission:		1,500,000 ordinary shares of 5 pence each on 20 July 2017
Period of return:	From:	09 February 2024	To:	09 August 2024
Balance of unallotted securities under scheme(s) from previous return:		375,505
Plus:    The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:    Number of securities issued/allotted under scheme(s) during period:		0
Equals:    Balance under scheme(s) not yet issued/allotted at end of period:		375,505

-Ends-

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher	020 7496 3000
Investec (Joint Broker) Gary Clarence Lydia Zychowska	020 7597 5970
Equity Development Hannah Crowe Matt Evans	020 7065 2692
ICR Consilium (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700 ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRGPUGGRUPCGPP